FairValueLabs Valuation System Value Investment
FN

Fabrinet (FN) Stock Analysis — Fair Value, Risk & Moat Rating

NYQ · Technology · Electronic Components

$570.22 Overvalued 3.73 (0.7%) As of Aug 13, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Caution
3.34
Altman Z-ScoreSafe Zone
$479.20
Fair ValueOvervalued (-19.0%)
3.4
Moat RatingNarrow moat
TL;DR · Audit Summary

Is Fabrinet a safe investment right now?

As of Aug 13, 2026, our estimated fair value (intrinsic value) for Fabrinet (FN) stock is $479.20, versus a market price of $570.22 — Overvalued. Predicted EPS $11.98 x 40.0 Fair PE.

Fabrinet's Altman Z-Score of 3.34 places it in the safe zone. Our fair value estimate is $479.20 (Overvalued). Moat rating: 3.4/5 stars.

Fabrinet is part of the Optical Modules & Interconnect — the Data-Center Nervous System group in our AI coverage — compare its fair value against every other AI, cloud, and quantum stock through a value investing lens.

Price Chart · FN
Section 01 · Financial Health

Could Fabrinet go bankrupt? Altman Z-Score analysis

3.34

Z-Score of 3.34 is above 3.0, indicating the company is financially healthy by this metric.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives FN's Z-Score?

Altman Z-Score components for FN
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA0.57181.20.69
B · Retained Earnings / Total AssetsRE / TA0.73931.41.04
C · EBIT / Total AssetsEBIT / TA0.12543.30.41
D · Market Cap / Total LiabilitiesMCap / TL0.00.60.0
E · Revenue / Total AssetsRev / TA1.20761.01.21

How has FN's financial health changed over time?

3.0 Safe1.8 Distress0.01.02.03.04.02022202320242025
FN Z-Score history
YearZ-ScoreZone
20223.18Safe
20233.52Safe
20243.47Safe
20253.34Safe

Source: Calculated from FN's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

Fabrinet Fair Value & Intrinsic Value — What Is It Actually Worth?

FVL Fair Value$479.20
vs
Market Price$570.22
Overvalued -19.0% Stock trades 19.0% above our estimated fair value of $479.20.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$11.98Proprietary blend of reported actuals (3Q actual) + analyst consensus, weighted by α
Last Year EPS$9.17Annual report (SEC EDGAR)
Analyst Consensus EPS (This Year)$13.819 analysts consensus
Trailing P/E49.1xCurrent market pricing
Fair P/E (β discount)40.0xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)GrowingDirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $732.44 (9 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does Fabrinet have a durable competitive advantage?

★★★☆☆
Narrow moat

Moat rating: 3.4/5.

What makes up FN's moat score?

ROIC Stability

★★★★☆

ROIC variability over the past decade. Score: 4/5.

Gross Margin Trend

★★★☆☆

Gross margin trajectory over the past decade. Score: 3/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is FN's return on invested capital?

0%-5%2%9%16%23%2022202320242025
FN ROIC history
YearROICTrend
202216.2%
202317.7%Rising
202417.8%Stable
202517.9%Stable

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is Fabrinet's dividend safe?

Status Suspended Fabrinet has suspended its dividend. No payout is currently being made to shareholders.
Section 05 · Financial Summary

Fabrinet's key financial metrics

FN financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $3.4B $2.9B $2.3B Rising
Net Income $0.3B $0.3B $0.2B Rising
Free Cash Flow $0.2B $0.4B $0.0B Rising
Gross Margin 12.1% 12.3% 12.3% Stable
Section 06 · Lab Signals

Recent events that affect our FN analysis

EARNINGS

FN earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $3.81. Revenue estimate: $1.28B. Our current Fair Value: $479.20 — a significant beat or miss could shift this estimate.

ANALYST

FN analyst consensus: 78% bullish (7 of 9 analysts)

Lab Impact

3 Strong Buy, 4 Buy, 2 Hold, 0 Sell, 0 Strong Sell. Consensus target: $732.44 (28.4% upside). Compare with our independent Fair Value: $479.20.

FILING

FN filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

FN beat EPS estimates by 4.4%

Lab Impact

Reported EPS: $3.72 vs estimate $3.56. Earnings strength supports our Fair Value of $479.20 (16.0% below current price).

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

FN beat EPS estimates by 3.4%

Lab Impact

Reported EPS: $3.36 vs estimate $3.25. Earnings strength supports our Fair Value of $479.20 (16.0% below current price).

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

FN beat EPS estimates by 3.6%

Lab Impact

Reported EPS: $2.92 vs estimate $2.82. Earnings strength supports our Fair Value of $479.20 (16.0% below current price).

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

EARNINGS

FN beat EPS estimates by 0.8%

Lab Impact

Reported EPS: $2.65 vs estimate $2.63. Earnings strength supports our Fair Value of $479.20 (16.0% below current price).

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

FN beat EPS estimates by 1.9%

Lab Impact

Reported EPS: $2.52 vs estimate $2.47. Earnings strength supports our Fair Value of $479.20 (16.0% below current price).

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

FN filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

FN beat EPS estimates by 4.7%

Lab Impact

Reported EPS: $2.61 vs estimate $2.49. Earnings strength supports our Fair Value of $479.20 (16.0% below current price).

FILING

FN filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

Section 07 · FAQ

Common questions about Fabrinet

What is Fabrinet stock price today?

Fabrinet (FN) stock price is $570.22 as of the latest market close, traded on the NYSE exchange.

What does Fabrinet do?

Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. It offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, packaging, integration, final assembly, and testing. Its products include switching products, including reconfigurable optical add-drop multiplexers, optical amplifiers, modulators, and other optical components and modules that enable network managers to route voice, video, and data communications traffic through fiber optic cables at various wavelengths, speeds, and over various distances.

What sector and industry is FN in?

Fabrinet operates in the Technology sector, specifically within the Electronic Components industry. It trades on the NYSE under the ticker symbol FN.

Is FN stock overvalued or undervalued?

Based on our valuation model, Fabrinet trades 19.0% above our fair value estimate — potentially overvalued.

  • FairValueLabs Fair Value: $479.20
  • Current Price: $570.22
  • Valuation Zone: Overvalued
What is FN stock forecast and analyst target price?

Based on 9 Wall Street analysts, the consensus price target for Fabrinet is $732.44, implying upside of 28.4% from the current price.

  • Analyst High Target: $850.00
  • Analyst Low Target: $635.00

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is Fabrinet revenue and earnings growing?

Here are the analyst consensus growth estimates for Fabrinet:

  • Revenue growth (current year est.): 34.6%
  • EPS growth (current year est.): 35.8%
  • Revenue growth (next year est.): 23.5%
  • EPS growth (next year est.): 25.4%
What are Fabrinet's key financial metrics?
MetricLatestTrend
Revenue$3.4BRising
Net Income$0.3BRising
Free Cash Flow$0.2BRising
Gross Margin12.1%Stable
What is FN's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 49.1x
  • Forward P/E (next 12 months est.): 32.9x
  • FairValueLabs Fair P/E: 40.0x
How volatile is FN stock?

Fabrinet has a beta of 1.22, meaning it is somewhat more volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does Fabrinet have?

Fabrinet's balance sheet shows:

  • Total Cash: $945.2M
  • Total Debt: $4.4M
  • Net Cash Position: $940.8M

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is Fabrinet's free cash flow?

Fabrinet generated $-79.2M in trailing twelve-month free cash flow (from $256.9M in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does Fabrinet pay a dividend?

Fabrinet does not currently pay a regular dividend to shareholders. The company may be reinvesting all profits back into growth, or it may have suspended its dividend.

Is Fabrinet at risk of going bankrupt?

Fabrinet's Altman Z-Score is 3.34, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does Fabrinet have a durable competitive advantage?

Fabrinet scores 3.4/5 stars (Narrow moat) in our moat analysis:

  • ROIC Stability: 4/5
  • Gross Margin Trend: 3/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is FN's return on equity (ROE)?

Fabrinet's return on equity is 20.0%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy FN stock?

FN shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol FN
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is FN a value stock or speculative?

FairValueLabs classifies Fabrinet as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.

Who is the CEO of Fabrinet?

The current CEO of Fabrinet is Mr. Seamus Grady.

What is FN's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $11.61
  • Forward EPS (next 12 months est.): $17.32
  • Analyst consensus EPS (this year): $13.81
  • Analyst consensus EPS (next year): $17.32

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Aug 13, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

FN analysis methodology: How we calculate fair value, Z-Scores, and moat ratings